In 2021, Eric Dube earned $1.28M in total compensation at Travere Therapeutics, Inc., including $710.00K salary and $553.80K bonus. Most recently sold 22,750 shares in Feb 2025. Currently holds stock worth $14.67M. 6+ years at the helm of Travere Therapeutics, Inc..
Compensation History
Annual executive compensation data for Eric Dube, including salary, bonuses, and stock awards.
Year
2021
Total Compensation
$1.28M
Salary
$710.00K
Bonus
$553.80K
Other
$11.86K
Salary
$710.00KBoard Justification
The compensation philosophy aims to attract, retain, and motivate executives through competitive compensation packages that align with company performance and peer benchmarking.
Bonus
$553.80KBoard Justification
The target bonus percentage was set at 65% of base salary for the Company’s CEO and was based on the achievement of corporate performance goals, with actual performance resulting in a payout of 78%.
Other Compensation
$11.86KBoard Justification
Other compensation includes health insurance premiums and 401(k) matching contributions.
Restricted Stock
Board Justification
No stock was reported as vested in 2021 for Eric Dube.
Performance Metrics
The performance metrics for determining the CEO's compensation included corporate performance goals related to pipeline advancement, patient service increase, and maintaining a robust organizational culture.
Eric Dube
CEO of Travere Therapeutics, Inc.
Education
Ph.D. from Cornell University
Field of Expertise
Healthcare & Life Sciences - Pharmaceuticals
Sector of Economy
Healthcare
Born
November 20, 1972 - 53 years ago
CEO of Travere Therapeutics, Inc. for
6 years 11 months (Jan 2019 - Present)
Previous Experience
Head, North America of Viiv Healthcare Limited
Other Travere Therapeutics, Inc. CEOs
Holdings
Track Eric Dube's stock holdings and portfolio value over time.
Total Stock Sold
$6.10M
$6.10M
298,332 TVTX shares
What if they kept their stock?
If Eric Dube didn't sell their stock, today they would have:
Extra TVTX298,332 shares worth $10.44M.
This is 71.08% and $4.34M more than what they got when they sold the stock.
Insider Trading
Eric Dube's recent stock transactions, purchases, and sales filed with the SEC.
$546.91K
TVTX at $24.04/share
Feb 11, 2025
Sale
$2.05M
TVTX at $20.21/share
Jan 31, 2025
Sale
260,000 shares
TVTX
Jan 31, 2025
Received
$417.85K
TVTX at $19.46/share
Jan 22, 2025
Sale
$243.36K
TVTX at $11.52/share
Sep 5, 2024
Sale
32,500 shares
TVTX
Sep 5, 2024
Received
$166.29K
TVTX at $8.70/share
Jan 31, 2024
Sale
135,000 shares
TVTX
Jan 31, 2024
Received
$70.54K
TVTX at $8.96/share
Jan 23, 2024
Sale
$65.53K
TVTX at $14.71/share
Aug 31, 2023
Sale
Rivals
Compare Eric Dube with competitor CEOs and industry peers.